Biotech Analyst Schimmer, along with CEO Kumar and CFO Trimarchi, participate in a conference call to discuss the positioning acoramidis in a competitive ATTR-CM field and going alone against some powerful ATTR-CM competitors on March 18 at 11 am hosted by Cantor Fitzgerald. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BBIO:
